Life sciences news

Autoimmune disorders increase risk of cardiovascular disease

Saturday August 27th 2022

Read more
Biocartis obtains ISO 27001 certification for information security management

Thursday August 25th 2022

Read more
Alexandra Clyde appointed to Sequana Medical Board of Directors

Thursday August 25th 2022

Read more
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

Thursday August 25th 2022

Read more
mRNA leading expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers investing in EUR 39M Series B2 financing of mRNA technology platform company eTheRNA

Tuesday August 23rd 2022

Read more
argenx announces European Commission approval of VYVGART™ (efgartigimod alfa-fcab) for the treatment of generalized myasthenia gravis

Thursday August 11th 2022

Read more
Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic

Wednesday August 10th 2022

Read more
Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

Monday August 8th 2022

Read more
Your news here?

Become a flanders.bio member
S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

Tuesday August 2nd 2022

Read more
Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

Monday August 1st 2022

Read more
NEXTSTELLIS® oral contraceptive now available in Australia

Tuesday July 26th 2022

Read more

More info?

Communication Coordinator